BAX

26.95

2.39% -0.66

시간 외 거래: 26.85 -0.10 -0.37%

박스터 인터내셔널 (BAX)

개요 뉴스 가격 이력 옵션 체인 Financials BAX 왜 하락? 토론 예측 주식 분할 배당 이력

전일 마감가:

$27.61

열려 있는:

$27.2

하루 거래량:

6.88M

Relative Volume:

0.99

시가총액:

$13.93B

수익:

$11.32B

순이익/손실:

$-981.00M

주가수익비율:

-13.80

EPS:

-1.9532

순현금흐름:

$714.00M

1주 성능:

-1.39%

1개월 성능:

+19.14%

6개월 성능:

+44.04%

1년 성능:

+12.39%

1일 변동 폭

$26.64

$27.40

1주일 범위

$26.56

$28.02

52주 변동 폭

$15.73

$30.00

박스터 인터내셔널 Stock (BAX) Company Profile

명칭

Baxter International Inc

부문

Healthcare (1075)

산업

Medical Instruments & Supplies (57)

전화

(224) 948-2000

주소

ONE BAXTER PARKWAY, DEERFIELD, IL

직원

37,500

트위터

@baxter_intl

다음 수익 날짜

2026-07-30

최신 SEC 제출 서류

BAX's Discussions on Twitter

Compare BAX vs ISRG, BDX, ALC, RMD, MDLN

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
BAX Baxter International Inc	26.95	14.27B	11.32B	-981.00M	714.00M	-1.9532
ISRG Intuitive Surgical Inc	401.27	141.75B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	183.58	49.41B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	73.58	36.42B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	226.00	32.61B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	35.50	30.74B	29.14B	1.07B	1.05B	1.1956

박스터 인터내셔널 Stock (BAX) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-10-31	다운그레이드	Argus	Buy → Hold
2025-08-04	다운그레이드	Stifel	Buy → Hold
2025-08-01	다운그레이드	Goldman	Buy → Neutral
2025-02-26	재개	Goldman	Buy
2025-02-24	업그레이드	Argus	Hold → Buy
2025-02-20	재개	Barclays	Overweight
2024-07-15	다운그레이드	Morgan Stanley	Equal-Weight → Underweight
2024-05-30	개시	Goldman	Neutral
2024-05-10	다운그레이드	TD Cowen	Buy → Hold
2023-05-30	재개	Morgan Stanley	Equal-Weight
2023-03-29	개시	UBS	Neutral
2023-01-06	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2023-01-05	다운그레이드	Raymond James	Outperform → Mkt Perform
2023-01-03	다운그레이드	BofA Securities	Buy → Neutral
2022-12-19	다운그레이드	JP Morgan	Overweight → Neutral
2022-12-15	다운그레이드	Deutsche Bank	Buy → Hold
2022-12-12	다운그레이드	Citigroup	Buy → Neutral
2022-10-18	개시	Barclays	Overweight
2022-10-12	개시	Jefferies	Hold
2022-06-24	다운그레이드	Wells Fargo	Overweight → Equal Weight
2022-04-04	다운그레이드	Goldman	Neutral → Sell
2022-03-02	재개	BofA Securities	Buy
2022-02-18	재확인	KeyBanc Capital Markets	Overweight
2022-02-18	재확인	Morgan Stanley	Overweight
2022-02-18	재확인	Raymond James	Outperform
2022-02-18	재확인	Stifel	Buy
2022-02-18	재확인	UBS	Neutral
2022-02-18	재확인	Wells Fargo	Overweight
2022-02-11	개시	Goldman	Neutral
2022-01-07	재개	Citigroup	Buy
2022-01-07	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2021-09-13	업그레이드	Cowen	Market Perform → Outperform
2021-09-03	업그레이드	Barclays	Equal Weight → Overweight
2021-05-25	개시	Barclays	Equal Weight
2021-01-29	다운그레이드	Piper Sandler	Overweight → Neutral
2021-01-06	다운그레이드	UBS	Buy → Neutral
2020-12-15	다운그레이드	Goldman	Buy → Neutral
2020-10-01	업그레이드	Citigroup	Neutral → Buy
2020-09-04	다운그레이드	Argus	Buy → Hold
2020-06-24	개시	Oppenheimer	Outperform
2020-03-19	업그레이드	Stifel	Hold → Buy
2020-03-18	업그레이드	KeyBanc Capital Markets	Sector Weight → Overweight
2020-03-05	개시	Citigroup	Neutral
2020-02-13	개시	Goldman	Buy
2020-01-02	업그레이드	Evercore ISI	In-line → Outperform
2019-12-17	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2019-06-26	개시	KeyBanc Capital Markets	Sector Weight
2019-04-08	다운그레이드	Evercore ISI	Outperform → In-line
2019-01-02	업그레이드	Citigroup	Neutral → Buy
2019-01-02	업그레이드	Morgan Stanley	Underweight → Overweight
2018-11-02	업그레이드	Argus	Hold → Buy
2018-10-16	개시	Barclays	Underweight
2018-05-17	재개	Piper Jaffray	Overweight
2018-02-06	재확인	Citigroup	Neutral
2018-01-03	개시	Evercore ISI	Outperform
2018-01-03	업그레이드	Raymond James	Mkt Perform → Outperform

모두보기

박스터 인터내셔널 주식(BAX)의 최신 뉴스

Aug 12, 2026

Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Aug 12, 2026

Baxter International interim CFO Anita Zielinski to resign in September By Investing.com - Investing.com Australia

Aug 12, 2026

Aug 11, 2026

Deepa Abi Joins Baxter International as Vice President, Global Business Solutions - hrtoday.in

Aug 11, 2026

Form 8K BAXTER INTERNATIONAL INC For: 11 August By Investing.com - Investing.com Nigeria

Aug 11, 2026

Baxter International interim CFO Anita Zielinski to resign in September - Investing.com

Aug 11, 2026

Baxter International Inc. (NYSE:BAX) Given Average Recommendation of "Reduce" by Analysts - MarketBeat

Aug 11, 2026

Baxter International (NYSE:BAX) Stock Crosses Above 200-Day Moving AverageHere's Why - MarketBeat

Aug 11, 2026

Aug 10, 2026

Baxter International Inc. (BAX) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential and Price Dynamics - DirectorsTalk Interviews

Aug 10, 2026

Aug 09, 2026

Join Class Action to Recover Losses from Baxter International, In - The National Law Review

Aug 09, 2026

Aug 08, 2026

DWS Health and Wellness Fund's Baxter International Inc(BAX) Holding History - GuruFocus

Aug 08, 2026

Aug 07, 2026

Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch

Aug 07, 2026

Aug 06, 2026

Baxter International Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Aug 06, 2026

Aug 05, 2026

Baxter International Inc (BAX) Stock Down 3.6% -- Now Undervalued? GF Score: 67/100 - GuruFocus

Aug 05, 2026

Baxter International Announces Upcoming CFO Leadership Transition - The Globe and Mail

Aug 05, 2026

Aug 04, 2026

Interim CFO exit at Baxter International (NYSE: BAX) set for Sept 15 - Stock Titan

Aug 04, 2026

Baxter International Inc Announces Resignation of Anita Zielinski from Interim Chief Financial Officer, Effective as of September 15, 2026 - marketscreener.com

Aug 04, 2026

Baxter International Inc. Announces Cash Tender Offers - marketscreener.com

Aug 04, 2026

JPMorgan Adjusts Price Target on Baxter International to $26 From $19, Maintains Neutral Rating - Moomoo

Aug 04, 2026

Baxter International launches $500M cash tender offers for select long-dated notes - tradingview.com

Aug 04, 2026

Aug 03, 2026

Baxter International Inc (BAX) Shares Surge 7.4% -- What GF Scor - GuruFocus

Aug 03, 2026

Baxter International Inc (BAX): A Closer Look Behind a 66 GF Sco - GuruFocus

Aug 03, 2026

UBS Raises Price Target on Baxter International to $28 From $25, Maintains Neutral Rating - Moomoo

Aug 03, 2026

Baxter International Inc. (BAX) Stock Analysis: Navigating Healthcare Opportunities with a 4.33% Potential Upside - DirectorsTalk Interviews

Aug 03, 2026

Baxter International Sees Unusually Large Options Volume (NYSE:BAX) - MarketBeat

Aug 03, 2026

Aug 01, 2026

Baxter International (BAX) Is Up 16.8% After Raising 2026 Sales Outlook And Earnings Guidance - Yahoo Finance

Aug 01, 2026

Jul 31, 2026

Baxter International Is Maintained at Equal-Weight by Wells Fargo - Moomoo

Jul 31, 2026

Jefferies & Co Adjusts Baxter International Price Target to $27 From $18, Maintains Hold Rating - Moomoo

Jul 31, 2026

Deutsche Bank Adjusts Baxter International PT to $27 From $20, Maintains Hold Rating - Moomoo

Jul 31, 2026

Citigroup Upgrades Baxter International to Neutral From Sell, Adjusts Price Target to $28 From $17 - Moomoo

Jul 31, 2026

Baxter International (NYSE:BAX) Stock Rating Upgraded by Citigroup - MarketBeat

Jul 31, 2026

Jul 30, 2026

Baxter International Inc (BAX) Shares Surge 8.0% -- What GF Score of 64 Tells Investors - GuruFocus

Jul 30, 2026

Baxter International 2026: Revenue $2.96B, EPS $0.24— 10-Q Summary - tradingview.com

Jul 30, 2026

Baxter International Inc (BAX) (Q2 2026) Earnings Call Highlight - GuruFocus

Jul 30, 2026

Baxter International Inc reports results for the quarter ended June 30Earnings Summary - tradingview.com

Jul 30, 2026

Baxter Turnaround Efforts Continue Under New Management Team - Morningstar

Jul 30, 2026

Baxter: Q2 Earnings Snapshot - KVUE

Jul 30, 2026

Baxter (BAX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Jul 30, 2026

Jul 28, 2026

Stifel raises Baxter stock price target on segment restructuring - Investing.com

Jul 28, 2026

UBS Adjusts Price Target on Baxter International to $25 From $19, Maintains Neutral Rating - Moomoo

Jul 28, 2026

Baxter issues recall of antibiotic IV bags after bits of cardboard flagged in solution - Fierce Pharma

Jul 28, 2026

Baxter International (BAX) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr

Jul 28, 2026

Stifel Adjusts Price Target on Baxter International to $24 From $19, Maintains Hold Rating - marketscreener.com

Jul 28, 2026

Analysts Offer Insights on Healthcare Companies: InflaRx (IFRX) and Baxter International (BAX) - The Globe and Mail

Jul 28, 2026

UBS Maintains Baxter International Inc(BAX.US) With Hold Rating, Raises Target Price to $25 - Moomoo

Jul 28, 2026

Why Baxter (BAX) Stock Is Up Today - Yahoo Finance

Jul 28, 2026

Jul 27, 2026

BAXTER ISSUES VOLUNTARY NATIONWIDE RECALL OF CEFAZOLIN IN DEXTROSE INJECTION, USP, 2G / 100ML (20MG / ML) SINGLE-DOSE INFUSION BAG IN 100ML DUE TO PARTICULATE MATTER FOUND IN SOLUTION - Solomon's Words for the Wise

Jul 27, 2026

Baxter International Inc (BAX) Shares Surge 4.2% -- What GF Scor - GuruFocus

Jul 27, 2026

Baxter International Inc (BAX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 27, 2026

Baxter International Q2 2026 Earnings Preview — July 30, Street Expects $0.37 EPS - AlphaStreet

Jul 27, 2026

TD Cowen Adjusts Price Target on Baxter International to $24 From $20, Maintains Hold Rating - Moomoo

Jul 27, 2026

BAX|Baxter International Inc|Price:23.335|Chg%:+0.935 - TradingKey

Jul 27, 2026